A Wiley journal has retracted more than two dozen articles in the last few months for peer review issues.
The articles, which appeared in Environmental Toxicology, have been retracted in batches, the latest on February 16-17, with previous sets in January and November.
The retraction notices of all 26 papers read in part:
The decision to abandon a process to re-evaluate a review recommending exercise therapy for chronic fatigue syndrome (ME/CFS) has reignited calls for the article to be withdrawn.
The 2019 version of the Cochrane Library review, “Exercise therapy for chronic fatigue syndrome,” has accumulated 67 citations, according to Clarivate’s Web of Science.
The review recommends exercise therapy to treat ME/CFS, a treatment approach that drew widespread criticism from the patient community and researchers, who say physical activity isn’t an adequate remedy for the condition. According to the petition, Cochrane’s former editor-in-chief admitted the review in question wasn’t “fit for purpose,” although the editor-in-chief’s statement did not use that phrase.
A journal formerly published by Hindawi has yet to publish any sort of notice on a paper sleuths reported for containing duplicated images 1.5 years ago.
According to Kevin Patrick, the sleuth who contacted the publisher in mid-2023, the episode “might be a useful case study” of the issues facing Wiley, which acquired Hindawi in 2021 and stopped using the brand name earlier this year after retracting thousands of papers and closing journals overrun by paper mills.
In April 2023, Elisabeth Bik left a comment on PubPeer, noting “several figures in this paper look identical to figures in a 2019 paper by some of the same authors,” which had been retracted. “I could not find wording about e.g. a republication of part of that study, and the 2019 paper is not included in the references,” she wrote.
In January 2022, The Oncologist switched publishers from Wiley to Oxford University Press.
Last month, the journal issued an extensive correction for one of its most popular articles, a 2020 paper that describes results of a clinical trial the authors claimed found a homeopathic intervention improved quality of life and survival for people with advanced lung cancer.
The article page that remains on Wiley’s website, however, does not reflect the recent correction.
The Journal of Cellular Physiology, a Wiley title, will retract two articles by an arthritis researcher the U.S. Department of Veterans Affairs found to have engaged in research misconduct, Retraction Watch has learned.
Last November, the VA published findings stating Hee-Jeong Im Sampen, formerly a research biologist at the Jesse Brown Veterans Affairs Medical Center in Chicago, faked images and inflated sample sizes in three published papers, a grant application, a presentation, and an unpublished manuscript.
Based on the findings, the VA banned Sampen, who publishes under the name Hee-Jeong Im, from conducting research for the department and requested retractions of the three publications.
Two years after a journal told sleuths it wouldn’t retract flawed papers, it changed course and pulled them.
Mark Bolland, a researcher at the University of Auckland in New Zealand who is no stranger to unearthing academic wrongdoing, first sent complaints about one of the papers to The International Journal of Gynecology and Obstetrics (IJGO) in March 2021. He said the data on bone mineral density in “Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis,” which has been cited 26 times according to Clarivate’s Web of Science, were “impossible.”
Bolland said the data the researchers reported were not consistent with the reference values provided by the maker of the device used to measure bone density in the study. The normal ranges are 0.96 +/- 0.12 g/cm2, whereas the experiment reported much lower values of 0.21-0.24 g/cm2.
In an email to Retraction Watch, Bolland’s colleague Andrew Grey called the data “laughable, frankly.”
On March 1, 2022, Eric Ross, then a psychiatrist-in-training in Boston, alerted two major publishers to a pair of disturbingly similar papers he suspected had been “fabricated.”
“The articles are written by the same corresponding author and contain much of the same unrealistic data,” Ross, now an assistant professor at the University of Vermont, in Burlington, wrote in an email whose recipients included the editors-in-chief of Wiley’s CNS Neuroscience & Therapeutics and Springer Nature’s Neurotherapeutics.
Ross listed several “red flags” he felt clearly pointed to “research misconduct” in the two papers, which reported on two separate clinical trials of new antidepressant add-on medications (metformin and cilostazol). He also emphasized that fake medical research could have real consequences:
A study purportedly of scars left by caesarean sections included women yet to undergo the surgery, say sleuths. But an investigation into the research by the author’s employer and the journal that published it found no evidence of research misconduct.
The paper, published in Wiley journal Ultrasound in Obstetrics and Gynecology, was flagged on PubPeer in February by Ben Mol, an ob-gyn researcher at Monash University in Australia whose efforts have led to scores of retractions and corrections, and Jim Thornton, emeritus professor of obstetrics and gynecology at the University of Nottingham, in the UK. The study looks at how the scar left behind on a woman’s uterus after a c-section is affected by the dilation of her cervix at the time of the procedure.
Wiley, whose Hindawi subsidiary has attracted thousands of paper mill papers that later needed to be retracted, has seen widespread paper mill activity among hundreds of its journals, it announced yesterday.
More than 270 of its titles rejected anywhere from 600 to 1,000 papers per month before peer review once they implemented a pilot of what the publisher calls its Papermill Detection service. That service flagged 10-13% of all of the 10,000 manuscripts submitted to those journals per month, Wiley told Retraction Watch.
Wiley said the service includes “six distinct tools,” including looking for similarities with known paper mill papers, searching for “tortured phrases” and other problematic passages, flagging “irregular publishing patterns by paper authors,” verifying researcher identity, detecting hallmarks of generative AI, and analyzing the relevance of a given manuscript to the journal.
In what has become a familiar refrain, more than 30 editors and advisors of an economics journal have resigned because they felt the publisher’s need for growth would increase the “risks of proliferation of poor-quality science.”
In a letter uploaded to Dropbox on February 7, the editors and advisors of the Journal of Economic Surveys said: “We no longer believed that the corporate policies and practices of the Journal’s publisher, Wiley, as we perceived them through several statements made by Wiley and the draft of a new editor agreement submitted to the attention of Editors-in-Chief and Managing Editors by Wiley, were coherent with ours.”
Despite involving a lawyer, the now-former editors said: